BRD4 and melanoma: Consistently, inhibition of AKR1C2 sensitized melanoma cells to ferroptosis and the genetic inhibition of BRD4 enhanced the ferroptosis induced by RSL3 suggesting that BET inhibitors sensitize melanoma cells to ferroptosis.